At EVERSANA, we are proud to be certified as a Great Place to Work across the globe. We’re fueled by our vision to create a healthier world. How? Our global team of more than 7,000 employees is committed to creating and delivering next-generation commercialization services to the life sciences industry. We are grounded in our cultural beliefs and serve more than 650 clients ranging from innovative biotech start-ups to established pharmaceutical companies. Our products, services and solutions help bring innovative therapies to market and support the patients who depend on them. Our jobs, skills and talents are unique, but together we make an impact every day. Join us!
Across our growing organization, we embrace diversity in backgrounds and experiences. Improving patient lives around the world is a priority, and we need people from all backgrounds and swaths of life to help build the future of the healthcare and the life sciences industry. We believe our people make all the difference in cultivating an inclusive culture that embraces our cultural beliefs. We are deliberate and self-reflective about the kind of team and culture we are building. We look for team members that are not only strong in their own aptitudes but also who care deeply about EVERSANA, our people, clients and most importantly, the patients we serve. We are EVERSANA.
The Oncology Account Specialist will be a part of EVERSANA/ Accord BioPharma's new sales team that is currently launching new product within the prostate cancer therapeutic category. This person will be developing and maintaining strong relationships with targeted health care providers (Urology & Oncology). The Oncology Account Specialists will gather key information related to targeted accounts/customers, will provide product information & clinical data to the customers, as well as deliver impactful core selling messages. The "OAS" will demonstrate a sense of urgency to prepare and successfully execute a new product launch plan for their assigned geography.
Accord BioPharma is the U.S. specialty division of India -based Intas Pharmaceuticals, Ltd., one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. The Company is known for its range of products in three important therapeutic areas, oncology, immunology and critical care. Accord BioPharma is developing an exciting portfolio of specialty, complex molecules and biosimilar products. It is committed to improving patient access as well as providing affordable treatment options. EVERSANA is excited and PROUD to partner with this fantastic organization!
EVERSANA Deployment Solutions offers our employees competitive compensation, fleet vehicle package, paid time off, company paid holidays, excellent training, employee development programs, 401K plan with an employer match, and an incredible list of comprehensive employer benefits that includes medical, dental, and vision insurance along with a whole host of other valuable programs.
ESSENTIAL DUTIES AND RESPONSIBILITIES:
Our employees are tasked with delivering excellent business results through the efforts of their teams. These results are achieved by:
EXPECTATIONS OF THE JOB:
#LI-EC2
MINIMUM KNOWLEDGE, SKILLS AND ABILITIES:
The requirements listed below are representative of the experience, education, knowledge, skill and/or abilities required.
PREFERRED QUALIFICATIONS:
OUR CULTURAL BELIEFS
Patient Minded - I act with the patient’s best interest in mind.
Client Delight - I own every client experience and its impact on results.
Take Action - I am empowered and hold myself accountable.
Grow Talent - I own my development and invest in the development of others.
Win Together - I passionately connect with anyone, anywhere, anytime to achieve results.
Communication Matters - I speak up to create transparent, thoughtful and timely dialogue.
Embrace Diversity - I create an environment of awareness and respect.
Our team is aware of recent fraudulent job offers in the market, misrepresenting EVERSANA. Recruitment fraud is a sophisticated scam commonly perpetrated through online services using fake websites, unsolicited e-mails, or even text messages claiming to be a legitimate company. Some of these scams request personal information and even payment for training or job application fees. Please know EVERSANA would never require personal information nor payment of any kind during the employment process. We respect the personal rights of all candidates looking to explore careers at EVERSANA.
From EVERSANA’s inception, Diversity, Equity & Inclusion have always been key to our success. We are an Equal Opportunity Employer, and our employees are people with different strengths, experiences, and backgrounds who share a passion for improving the lives of patients and leading innovation within the healthcare industry. Diversity not only includes race and gender identity, but also age, disability status, veteran status, sexual orientation, religion, and many other parts of one’s identity. All of our employees’ points of view are key to our success, and inclusion is everyone's responsibility.
Consistent with the Americans with Disabilities Act (ADA) and applicable state and local laws, it is the policy of EVERSANA to provide reasonable accommodation when requested by a qualified applicant or candidate with a disability, unless such accommodation would cause an undue hardship for EVERSANA. The policy regarding requests for reasonable accommodations applies to all aspects of the hiring process. If reasonable accommodation is needed to participate in the interview and hiring process, please contact us at [email protected].
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
A Vision to Advance Life Sciences Services “Sana” is latin for healthy. So naturally, when service leaders – spanning the patient experience to global channel distribution – combined into one powerful platform, we became EVERSANA. Together, we w...
77 jobsSubscribe to Rise newsletter